115 related articles for article (PubMed ID: 25882391)
1. Sensitivity of the modified Children's Yale-Brown Obsessive Compulsive Scale to detect change: Results from two multi-site trials.
Scahill L; Sukhodolsky DG; Anderberg E; Dimitropoulos A; Dziura J; Aman MG; McCracken J; Tierney E; Hallett V; Katz K; Vitiello B; McDougle C
Autism; 2016 Feb; 20(2):145-52. PubMed ID: 25882391
[TBL] [Abstract][Full Text] [Related]
2. Children's Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders.
Scahill L; McDougle CJ; Williams SK; Dimitropoulos A; Aman MG; McCracken JT; Tierney E; Arnold LE; Cronin P; Grados M; Ghuman J; Koenig K; Lam KS; McGough J; Posey DJ; Ritz L; Swiezy NB; Vitiello B;
J Am Acad Child Adolesc Psychiatry; 2006 Sep; 45(9):1114-23. PubMed ID: 16926619
[TBL] [Abstract][Full Text] [Related]
3. Glutamatergic medication in the treatment of obsessive compulsive disorder (OCD) and autism spectrum disorder (ASD) - study protocol for a randomised controlled trial.
Häge A; Banaschewski T; Buitelaar JK; Dijkhuizen RM; Franke B; Lythgoe DJ; Mechler K; Williams SC; Dittmann RW;
Trials; 2016 Mar; 17(1):141. PubMed ID: 26983548
[TBL] [Abstract][Full Text] [Related]
4. Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology.
McDougle CJ; Scahill L; Aman MG; McCracken JT; Tierney E; Davies M; Arnold LE; Posey DJ; Martin A; Ghuman JK; Shah B; Chuang SZ; Swiezy NB; Gonzalez NM; Hollway J; Koenig K; McGough JJ; Ritz L; Vitiello B
Am J Psychiatry; 2005 Jun; 162(6):1142-8. PubMed ID: 15930063
[TBL] [Abstract][Full Text] [Related]
5. Children's Yale-Brown obsessive compulsive scale in autism spectrum disorder: component structure and correlates of symptom checklist.
Scahill L; Dimitropoulos A; McDougle CJ; Aman MG; Feurer ID; McCracken JT; Tierney E; Pu J; White S; Lecavalier L; Hallett V; Bearss K; King B; Arnold LE; Vitiello B
J Am Acad Child Adolesc Psychiatry; 2014 Jan; 53(1):97-107.e1. PubMed ID: 24342389
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Augmentation of Cognitive Behavior Therapy With Weight-Adjusted d-Cycloserine vs Placebo in Pediatric Obsessive-Compulsive Disorder: A Randomized Clinical Trial.
Storch EA; Wilhelm S; Sprich S; Henin A; Micco J; Small BJ; McGuire J; Mutch PJ; Lewin AB; Murphy TK; Geller DA
JAMA Psychiatry; 2016 Aug; 73(8):779-88. PubMed ID: 27367832
[TBL] [Abstract][Full Text] [Related]
7. Brief Report: social disability in autism spectrum disorder: results from Research Units on Pediatric Psychopharmacology (RUPP) Autism Network trials.
Scahill L; Hallett V; Aman MG; McDougle CJ; Eugene Arnold L; McCracken JT; Tierney E; Deng Y; Dziura J; Vitiello B;
J Autism Dev Disord; 2013 Mar; 43(3):739-46. PubMed ID: 23104617
[TBL] [Abstract][Full Text] [Related]
8. Psychometric properties of the Children's Yale-Brown Obsessive Compulsive Scale in youth with autism spectrum disorders and obsessive-compulsive symptoms.
Wu MS; McGuire JF; Arnold EB; Lewin AB; Murphy TK; Storch EA
Child Psychiatry Hum Dev; 2014; 45(2):201-11. PubMed ID: 23827959
[TBL] [Abstract][Full Text] [Related]
9. Development and Psychometric Evaluation of the Children's Yale-Brown Obsessive-Compulsive Scale Second Edition.
Storch EA; McGuire JF; Wu MS; Hamblin R; McIngvale E; Cepeda SL; Schneider SC; Rufino KA; Rasmussen SA; Price LH; Goodman WK
J Am Acad Child Adolesc Psychiatry; 2019 Jan; 58(1):92-98. PubMed ID: 30577944
[TBL] [Abstract][Full Text] [Related]
10. The Brief Obsessive-Compulsive Scale (BOCS): a self-report scale for OCD and obsessive-compulsive related disorders.
Bejerot S; Edman G; Anckarsäter H; Berglund G; Gillberg C; Hofvander B; Humble MB; Mörtberg E; Råstam M; Ståhlberg O; Frisén L
Nord J Psychiatry; 2014 Nov; 68(8):549-59. PubMed ID: 24568661
[TBL] [Abstract][Full Text] [Related]
11. Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study.
Erzegovesi S; Guglielmo E; Siliprandi F; Bellodi L
Eur Neuropsychopharmacol; 2005 Jan; 15(1):69-74. PubMed ID: 15572275
[TBL] [Abstract][Full Text] [Related]
12. Adapted cognitive behavior therapy for obsessive-compulsive disorder with co-occurring autism spectrum disorder: A clinical effectiveness study.
Flygare O; Andersson E; Ringberg H; Hellstadius AC; Edbacken J; Enander J; Dahl M; Aspvall K; Windh I; Russell A; Mataix-Cols D; Rück C
Autism; 2020 Jan; 24(1):190-199. PubMed ID: 31187645
[TBL] [Abstract][Full Text] [Related]
13. Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity.
Scahill L; Riddle MA; McSwiggin-Hardin M; Ort SI; King RA; Goodman WK; Cicchetti D; Leckman JF
J Am Acad Child Adolesc Psychiatry; 1997 Jun; 36(6):844-52. PubMed ID: 9183141
[TBL] [Abstract][Full Text] [Related]
14. The Yale-Brown Obsessive Compulsive Scale. II. Validity.
Goodman WK; Price LH; Rasmussen SA; Mazure C; Delgado P; Heninger GR; Charney DS
Arch Gen Psychiatry; 1989 Nov; 46(11):1012-6. PubMed ID: 2510699
[TBL] [Abstract][Full Text] [Related]
15. Effect of Fluoxetine on Obsessive-Compulsive Behaviors in Children and Adolescents With Autism Spectrum Disorders: A Randomized Clinical Trial.
Reddihough DS; Marraffa C; Mouti A; O'Sullivan M; Lee KJ; Orsini F; Hazell P; Granich J; Whitehouse AJO; Wray J; Dossetor D; Santosh P; Silove N; Kohn M
JAMA; 2019 Oct; 322(16):1561-1569. PubMed ID: 31638682
[TBL] [Abstract][Full Text] [Related]
16. Obsessive-compulsive symptoms in a randomized, double-blind study with olanzapine or risperidone in young patients with early psychosis.
van Nimwegen L; de Haan L; van Beveren N; Laan W; van den Brink W; Linszen D
J Clin Psychopharmacol; 2008 Apr; 28(2):214-8. PubMed ID: 18344733
[TBL] [Abstract][Full Text] [Related]
17. Children's Florida Obsessive Compulsive Inventory: psychometric properties and feasibility of a self-report measure of obsessive-compulsive symptoms in youth.
Storch EA; Khanna M; Merlo LJ; Loew BA; Franklin M; Reid JM; Goodman WK; Murphy TK
Child Psychiatry Hum Dev; 2009 Sep; 40(3):467-83. PubMed ID: 19326209
[TBL] [Abstract][Full Text] [Related]
18. Obsessive-compulsive symptoms during treatment with olanzapine and risperidone: a prospective study of 113 patients with recent-onset schizophrenia or related disorders.
de Haan L; Beuk N; Hoogenboom B; Dingemans P; Linszen D
J Clin Psychiatry; 2002 Feb; 63(2):104-7. PubMed ID: 11874209
[TBL] [Abstract][Full Text] [Related]
19. Convergent and discriminant validity of the Children's Yale-Brown Obsessive Compulsive Scale-Symptom Checklist.
Gallant J; Storch EA; Merlo LJ; Ricketts ED; Geffken GR; Goodman WK; Murphy TK
J Anxiety Disord; 2008 Dec; 22(8):1369-76. PubMed ID: 18329843
[TBL] [Abstract][Full Text] [Related]
20. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability.
Goodman WK; Price LH; Rasmussen SA; Mazure C; Fleischmann RL; Hill CL; Heninger GR; Charney DS
Arch Gen Psychiatry; 1989 Nov; 46(11):1006-11. PubMed ID: 2684084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
